MicroRNA and Cardiac Stem Cell Therapy

Serradifalco, C

Risultato della ricerca: Article

Abstract

Cardiac Progenitor Cells (CPCs) are multipotent cells of the myocardium. They are located inside niches of the heart muscle, can be isolated, characterized and used for cardiac regeneration in stem cell therapy. Actually, CPCs may be isolated by tissue digestion with or without cell sorting, but it is difficult to achieve the maximum level of differentiation when these cells are implanted into a damaged myocardium. The knowledge recently acquired on small molecules of non-coding RNAs, microRNA (miRNA), may improve the use of these cells in stem cell therapy. In fact, these small molecules may be attached to devices or adminstered as they are or in combination with nanoparticles in order to drive the correct differentiation of stem cells. Regarding heart regeneration, we can acquire knowledge from the role of miRNAs in heart development and use it to reprogram CPCs to gain the correct three-dimensional structure of the cardiac muscle.
Lingua originaleEnglish
pagine (da-a)-
Numero di pagine8
RivistaJOURNAL OF CLINICAL & EXPERIMENTAL CARDIOLOGY
Volume3
Stato di pubblicazionePublished - 2012

Fingerprint

Cell- and Tissue-Based Therapy
MicroRNAs
Stem Cells
Myocardium
Regeneration
Small Untranslated RNA
Nanoparticles
Cell Differentiation
Digestion
Equipment and Supplies

Cita questo

MicroRNA and Cardiac Stem Cell Therapy. / Serradifalco, C.

In: JOURNAL OF CLINICAL & EXPERIMENTAL CARDIOLOGY, Vol. 3, 2012, pag. -.

Risultato della ricerca: Article

@article{8229c664a81b4c93abdca59b6ec86256,
title = "MicroRNA and Cardiac Stem Cell Therapy",
abstract = "Cardiac Progenitor Cells (CPCs) are multipotent cells of the myocardium. They are located inside niches of the heart muscle, can be isolated, characterized and used for cardiac regeneration in stem cell therapy. Actually, CPCs may be isolated by tissue digestion with or without cell sorting, but it is difficult to achieve the maximum level of differentiation when these cells are implanted into a damaged myocardium. The knowledge recently acquired on small molecules of non-coding RNAs, microRNA (miRNA), may improve the use of these cells in stem cell therapy. In fact, these small molecules may be attached to devices or adminstered as they are or in combination with nanoparticles in order to drive the correct differentiation of stem cells. Regarding heart regeneration, we can acquire knowledge from the role of miRNAs in heart development and use it to reprogram CPCs to gain the correct three-dimensional structure of the cardiac muscle.",
keywords = "Cardiac stem cells; Heart regeneration; microRNA; Epigenetic; Reprogramming",
author = "{Serradifalco, C} and Giovanni Zummo and {Di Felice}, Valentina",
year = "2012",
language = "English",
volume = "3",
pages = "--",
journal = "Journal of Clinical and Experimental Cardiology",
issn = "2155-9880",
publisher = "OMICS Publishing Group",

}

TY - JOUR

T1 - MicroRNA and Cardiac Stem Cell Therapy

AU - Serradifalco, C

AU - Zummo, Giovanni

AU - Di Felice, Valentina

PY - 2012

Y1 - 2012

N2 - Cardiac Progenitor Cells (CPCs) are multipotent cells of the myocardium. They are located inside niches of the heart muscle, can be isolated, characterized and used for cardiac regeneration in stem cell therapy. Actually, CPCs may be isolated by tissue digestion with or without cell sorting, but it is difficult to achieve the maximum level of differentiation when these cells are implanted into a damaged myocardium. The knowledge recently acquired on small molecules of non-coding RNAs, microRNA (miRNA), may improve the use of these cells in stem cell therapy. In fact, these small molecules may be attached to devices or adminstered as they are or in combination with nanoparticles in order to drive the correct differentiation of stem cells. Regarding heart regeneration, we can acquire knowledge from the role of miRNAs in heart development and use it to reprogram CPCs to gain the correct three-dimensional structure of the cardiac muscle.

AB - Cardiac Progenitor Cells (CPCs) are multipotent cells of the myocardium. They are located inside niches of the heart muscle, can be isolated, characterized and used for cardiac regeneration in stem cell therapy. Actually, CPCs may be isolated by tissue digestion with or without cell sorting, but it is difficult to achieve the maximum level of differentiation when these cells are implanted into a damaged myocardium. The knowledge recently acquired on small molecules of non-coding RNAs, microRNA (miRNA), may improve the use of these cells in stem cell therapy. In fact, these small molecules may be attached to devices or adminstered as they are or in combination with nanoparticles in order to drive the correct differentiation of stem cells. Regarding heart regeneration, we can acquire knowledge from the role of miRNAs in heart development and use it to reprogram CPCs to gain the correct three-dimensional structure of the cardiac muscle.

KW - Cardiac stem cells; Heart regeneration; microRNA; Epigenetic; Reprogramming

UR - http://hdl.handle.net/10447/64911

UR - http://dx.doi.org/10.4172/2155-9880.S11-001

M3 - Article

VL - 3

SP - -

JO - Journal of Clinical and Experimental Cardiology

JF - Journal of Clinical and Experimental Cardiology

SN - 2155-9880

ER -